RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MENZELLA F
Collezione AO Ordine Mauriziano

Items : 9

Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study. in Journal of asthma and allergy / J Asthma Allergy. 2024 Mar 27;17:273-290. doi: 10.2147/JAA.S438981. eCollection 2024.

2024
AO Ordine Mauriziano

Cameli P; Aliani M; Altieri E; Bracciale P; Brussino L; Caiaffa MF; Canonica GW; Caruso C; Centanni S; D'Amato M; De Michele F; Del Giacco S; Di Marco F; Pelaia G; Rogliani P; Romagnoli M; Schino P; Schroeder JW; Senna G; Vultaggio A; Benci M; Boarino S; Menzella F;

Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study. in Respiratory research / Respir Res. 2023 May 20;24(1):135. doi: 10.1186/s12931-023-02439-w.

2023
AO Ordine Mauriziano

Vultaggio A; Aliani M; Altieri E; Bracciale P; Brussino L; Caiaffa MF; Cameli P; Canonica GW; Caruso C; Centanni S; D'Amato M; De Michele F; Del Giacco S; Di Marco F; Menzella F; Pelaia G; Rogliani P; Romagnoli M; Schino P; Senna G; Benci M; Boarino S; Schroeder JW;

ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study. in Respiratory research / Respir Res. 2022 Feb 19;23(1):36. doi: 10.1186/s12931-022-01952-8.

2022
AO Ordine Mauriziano

Menzella F; Bargagli E; Aliani M; Bracciale P; Brussino L; Caiaffa MF; Caruso C; Centanni S; D'Amato M; Del Giacco S; De Michele F; Di Marco F; Pastorello EA; Pelaia G; Rogliani P; Romagnoli M; Schino P; Senna G; Vultaggio A; Simoni L; Ori A; Boarino S; Vitiello G; Altieri E; Canonica GW;

Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm(3): A Post Hoc Analysis from the ANANKE Study. in Journal of asthma and allergy / J Asthma Allergy. 2022 Nov 10;15:1593-1604. doi: 10.2147/JAA.S383012. eCollection 2022.

2022
AO Ordine Mauriziano

Senna G; Aliani M; Altieri E; Bracciale P; Brussino L; Caiaffa MF; Cameli P; Canonica GW; Caruso C; D'Amato M; De Michele F; Del Giacco S; Di Marco F; Menzella F; Pelaia G; Rogliani P; Romagnoli M; Schino P; Schroeder JW; Vultaggio A; Rizzoli S; Zullo A; Boarino S; Palmisano M; Rossi A; Vitiello G; Centanni S;

Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis. in Frontiers in medicine / Front Med (Lausanne). 2022 Sep 2;9:950883. doi: 10.3389/fmed.2022.950883. eCollection 2022.

2022
AO Ordine Mauriziano

Caruso C; Cameli P; Altieri E; Aliani M; Bracciale P; Brussino L; Caiaffa MF; Canonica GW; Centanni S; D'Amato M; Del Giacco S; De Michele F; Pastorello EA; Pelaia G; Rogliani P; Romagnoli M; Schino P; Caminati M; Vultaggio A; Zullo A; Rizzoli S; Boarino S; Vitiello G; Menzella F; Di Marco F;

Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis. in Frontiers in allergy / Front Allergy. 2022 May 18;3:881218. doi: 10.3389/falgy.2022.881218. eCollection 2022.

2022
AO Ordine Mauriziano

D'Amato M; Menzella F; Altieri E; Bargagli E; Bracciale P; Brussino L; Caiaffa MF; Canonica GW; Caruso C; Centanni S; De Michele F; Di Marco F; Pastorello EA; Pelaia G; Rogliani P; Romagnoli M; Schino P; Senna G; Vultaggio A; Ori A; Simoni L; Boarino S; Vitiello G; Aliani M; Del Giacco S;

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life. in The World Allergy Organization journal / World Allergy Organ J. 2021 Jan 27;14(2):100509. doi: 10.1016/j.waojou.2021.100509. eCollection 2021

2021
AO Ordine Mauriziano
AOU Città della Salute di Torino

Canevari RF; Bucca C; Manfredi A; Lombardi C; Milanese M; Senna G; Paggiaro P; Canonica GW; Menzella F; Heffler E; Rolla G; Caminati M; Povero M; Pradelli L; Brussino L; Bagnasco D; Passalacqua G;

The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life. in Allergy / Allergy. 2020 Jun;75(6):1460-1463. doi: 10.1111/all.14135. Epub 2020 Feb 23.

2020
AO Ordine Mauriziano
AOU Città della Salute di Torino

Senna G; Testino E; Passalacqua G; Rolla G; Riccio AM; Milanese M; Paoletti G; Menzella F; Heffler E; Lombardi C; Guida G; De Ferrari L; Caruso C; D'Amato M; Canonica GW; Caminati M; Bucca C; Brussino L; Bonavia M; Massolo A; Bagnasco D;

One year of mepolizumab. Efficacy and safety in real-life in Italy. in Pulmonary pharmacology & therapeutics / Pulm Pharmacol Ther. 2019 Oct;58:101836. doi: 10.1016/j.pupt.2019.101836. Epub 2019 Aug 29.

2019
AO Ordine Mauriziano
AOU Città della Salute di Torino

Riccio AM; Bonavia M; Senna G; Guida G; Caruso C; Manfredi A; Testino E; Paoletti G; Heffler E; Bucca C; Lombardi C; Rolla G; Milanese M; Caminati M; Menzella F; Bagnasco D; Canonica GW; Passalacqua G;